Clinical Trial Update: Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors [NA]

View source ↗

Summary

Tamoxifen was studied in a completed clinical trial to prevent breast cancer in survivors of Hodgkin's disease. The study was sponsored by Dana-Farber Cancer In…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hodgkin Disease

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Hodgkin's Disease, Breast Cancer | NA | Status: COMPLETED